Edition:
United Kingdom

People: Diplomat Pharmacy Inc (DPLO.N)

DPLO.N on New York Stock Exchange

14.32USD
14 Dec 2018
Change (% chg)

$-0.38 (-2.59%)
Prev Close
$14.70
Open
$14.53
Day's High
$14.73
Day's Low
$14.20
Volume
121,671
Avg. Vol
227,250
52-wk High
$28.74
52-wk Low
$13.33

Hagerman, Philip 

Mr. Philip R. Hagerman is Chairman Emeritus of Diplomat Pharmacy, Inc. Previously served as Diplomat's Chief Executive Officer and Chairman of the Board of Directors. He has been a director since 1991. Mr. Hagerman co-founded Diplomat with his father in 1975. Mr. Hagerman led Diplomat as its principal executive officer and Chairman of the Board of Directors, and his service as a director has continued for approximately 26 years. He has a unique perspective and understanding of our business, culture and history, having led Diplomat through many economic cycles and operational initiatives. His many years of day-to-day leadership of Diplomat gives him critical insights into our operations, strategy and competition. Throughout his career at Diplomat, he demonstrated strong entrepreneurial skills, as well as regulatory, marketing, strategic, and operational expertise. Mr. Hagerman also possesses in-depth knowledge of, and key relationships in, the specialty pharmacy industry on a national basis.

Basic Compensation

Total Annual Compensation, USD 352,469
Restricted Stock Award, USD 110,003
Long-Term Incentive Plans, USD --
All Other, USD 1,010,200
Fiscal Year Total, USD 1,472,670

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Brian Griffin

--

Philip Hagerman

1,472,670

Joel Saban

1,523,460

Atul Kavthekar

1,583,260

Gary Rice

601,564

Benjamin Wolin

256,239
As Of  31 Dec 2017